Florida Department of Health EP418218

Purchase of Vaccines or Sera from GlaxoSmithKline LLC by Florida Department of Health

The Florida Department of Health, a state agency, issued a purchase order to GlaxoSmithKline LLC for vaccines or sera, specifically Hepatitis B and TDaP, under contract number EP418218. The order, valued at $942.00, was placed on May 28, 2025, and is part of a single-transaction procurement for the 2024/2025 period. The purchase involves vaccines production services, with the Florida Department of Health acting as the buyer and GlaxoSmithKline LLC as the vendor. The award is for a contract under $2,500, with no specified end date beyond June 30, 2025. The procurement was conducted under Florida's Rule 60A-1.002(2), F.A.C.

Description

643660-24/25-PB-GSK-HepB-TDaP